Insta
Union Govt Issues License To Five More Companies To Produce Liposomal Amphotericin B Used To Treat Black Fungus
A Representative Image
The Union Government has given licenses to five more companies to produce Liposomal Amphotericin B injections as per a report in All India Radio.
Liposomal Amphotericin B is used in the treatment of Mucormycosis. Prime Minister Narendra Modi had directed officials to procure the drug from anywhere it is available in the world.
Indian missions across the world have been committed to obtaining the supplies of this drug.
Gilead Sciences, a research-based biopharmaceutical company in the USA, is facilitating the supply of AmBisome to India through Mylan.
Over 1,21,000 vials have so far reached India. Another 85,000 vials are on the way. The company is likely to supply one million doses of AmBisome to India through Mylan, a company owned by Pfizer.
Maharashtra-based Genetic Life Sciences has also begun manufacturing Amphotericin B Emulsion injections; injections are priced at Rs 1,200 each, Union Minister Nitin Gadkari tweeted.
India has reported 11,717 cases of Mucormycosis until 26 May, with Gujarat, Maharashtra and Andhra Pradesh registering the highest number of cases.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
